Condition: Traumatic Brain Injury · Sponsor: Hope Biosciences LLC
The global objective of this study is to establish the safety and investigate the potential treatment effect of an intravenous infusion of HB-adMSCs (Hope Biosciences adipose-derived mesenchymal stem cells) on brain structure, neurocognitive/functional outcomes, and neuroinflammation after traumatic brain injury.
This description comes directly from the study's public registry record.
Carmen Duron, RN, MHA, BSN · 713-500-7395 · Maria.Carmen.Duron@uth.tmc.edu
Carla Mendoza, BSN, RN · 713-500-8206 · Carla.D.Wilkerson@uth.tmc.edu
Always discuss trial participation with your own doctor first.
| Memorial Hermann Hospital / UTHealth McGovern Medical School at Houston | Houston, Texas, United States | Recruiting |
| The University of Texas Health Science at San Antonio | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05951777